GO:0019199 transmembrane receptor protein kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019199 defines the molecular function of combining with a signal and transmitting it across a membrane by catalyzing protein phosphorylation (protein + ATP = phosphoprotein + ADP).
• This activity is intrinsic to transmembrane receptors such as the insulin receptor and bacterial sensor kinases, enabling cells to convert extracellular cues into intracellular signals.
• The catalytic mechanism involves ATP binding, substrate protein docking, and phosphotransfer, often regulated by ligand-induced dimerization or conformational changes.
• Key genes include INSR, EGFR, and bacterial histidine kinases like AgrC, which are studied in cancer, diabetes, and infectious disease research.
• Dysregulation of transmembrane receptor protein kinase activity is linked to cancer, metabolic disorders, and bacterial pathogenesis.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of receptor kinase function in health and disease.
Description
Transmembrane receptor protein kinase activity (GO:0019199) is a fundamental molecular function that allows cells to sense extracellular signals and convert them into intracellular phosphorylation events. This activity is defined by the combination with a signal and transmission across a membrane, catalyzing the transfer of a phosphate group from ATP to a protein substrate. It is central to signal transduction pathways in organisms ranging from bacteria to humans, governing processes such as growth, metabolism, and chemotaxis. Researchers study this activity to understand how cells communicate with their environment and how disruptions contribute to diseases including cancer and diabetes. The insulin receptor was among the first characterized examples, demonstrating intrinsic tyrosine kinase activity that is essential for metabolic signaling. Bacterial sensor kinases such as AgrC and chemotaxis receptors illustrate the diversity of transmembrane signaling mechanisms. Understanding GO:0019199 provides a framework for investigating receptor-ligand interactions, kinase activation, and downstream signaling networks.
transmembrane receptor protein kinase activity At A Glance
| GO ID | GO:0019199 |
|---|---|
| GO term | transmembrane receptor protein kinase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Signal reception and transmembrane transmission via protein phosphorylation |
| Catalytic reaction | protein + ATP = phosphoprotein + ADP |
| Cellular location | Transmembrane receptor proteins |
| Example receptors | Insulin receptor, AgrC, chemotaxis receptors |
What Is GO:0019199?
GO:0019199 describes a molecular function in which a transmembrane receptor binds a signal and transmits it across the membrane to initiate a cellular change by catalyzing the phosphorylation of a protein substrate using ATP. The reaction converts a protein and ATP into a phosphoprotein and ADP, representing a key step in signal transduction. This activity is intrinsic to the receptor itself, distinguishing it from non-transmembrane kinases that may be recruited downstream.
Why Is transmembrane receptor protein kinase activity Important in Cell Biology?
Transmembrane receptor protein kinase activity is essential for converting extracellular signals into intracellular responses, impacting nearly every aspect of cell physiology. Its dysfunction is implicated in major human diseases, including cancer, diabetes, and bacterial infections, making it a prime target for therapeutic intervention. Understanding this activity at the molecular level informs drug discovery and precision medicine.
• Enables cells to respond to hormones, growth factors, and environmental cues.
• Critical for metabolic regulation, as shown by the insulin receptor kinase.
• Drives bacterial pathogenesis through sensor kinases like AgrC.
• Plays a role in chemotaxis and adaptive responses in bacteria.
• Mutations in receptor kinases are linked to cancer and developmental disorders.
• Serves as a target for kinase inhibitors in oncology and metabolic diseases.
• Provides a model for studying transmembrane signaling mechanisms.
• Facilitates comparative analysis of eukaryotic and prokaryotic signaling.
• Underpins synthetic biology approaches to engineer signal transduction.
• Essential for understanding drug resistance mechanisms in infectious diseases.
What Happens During transmembrane receptor protein kinase activity?
Signal Binding and Receptor Activation
In simple terms: The receptor catches a signal outside the cell and changes shape to start working.
The process begins when an extracellular signal, such as a hormone or a bacterial autoinducer, binds to the receptor's extracellular domain. This binding induces conformational changes that are transmitted across the membrane, often through dimerization or rearrangement of transmembrane helices. For the insulin receptor, ligand binding activates its intrinsic tyrosine kinase activity, leading to autophosphorylation. In bacterial chemotaxis receptors, ligand binding modulates the activity of associated kinases.
Transmembrane Signal Transmission
In simple terms: The signal travels through the membrane to the inside of the cell.
The activated receptor undergoes structural changes that propagate through the transmembrane domain to the cytoplasmic kinase domain. This transmission often involves rotation or piston-like movements of transmembrane helices, as described for bacterial chemotaxis receptors. In AgrC, a histidine protein kinase, the transmembrane topology is critical for signal recognition and transduction. The efficiency of transmission can be regulated by the membrane environment and receptor oligomerization.
Catalytic Phosphorylation
In simple terms: The receptor uses ATP to add a phosphate tag to a target protein.
Once activated, the cytoplasmic kinase domain catalyzes the transfer of the gamma-phosphate from ATP to specific tyrosine, serine, or histidine residues on substrate proteins. This reaction produces a phosphoprotein and ADP, as defined by GO:0019199. For tyrosine kinases like the insulin receptor, autophosphorylation enhances catalytic activity and creates docking sites for downstream signaling proteins. In bacterial histidine kinases, phosphorylation occurs on a conserved histidine residue, initiating a phosphorelay.
Downstream Signaling and Cellular Response
In simple terms: The phosphate tag triggers a chain reaction inside the cell.
Phosphorylated substrates initiate signaling cascades that alter cell activity, such as gene expression, metabolism, or motility. In T cells, non-transmembrane tyrosine kinases are temporally regulated following antigen receptor engagement, highlighting the integration of receptor kinase activity with downstream events. Bacterial chemotaxis relies on phosphorylation events that control flagellar rotation. The specificity of downstream responses is determined by the substrate repertoire and scaffold proteins.
Key Genes Involved in GO:0019199 transmembrane receptor protein kinase activity
The following genes encode transmembrane receptor protein kinases or closely related signaling components that are central to GO:0019199.
| Gene | Major Role | Research Relevance |
|---|---|---|
| INSR | Insulin receptor tyrosine kinase; mediates metabolic signaling | Diabetes, insulin resistance, cancer |
| EGFR | Epidermal growth factor receptor tyrosine kinase | Cancer, targeted therapy |
| AGR C | Histidine protein kinase sensor in Staphylococcus aureus | Bacterial virulence, quorum sensing |
| CHEA | Histidine kinase in bacterial chemotaxis | Signal transduction, chemotaxis |
| TCR | T cell antigen receptor complex; associates with kinases | Immune signaling, T cell activation |
| CNR1 | Cannabinoid receptor 1; G protein-coupled, modulates kinase pathways | Neurobiology, signaling |
| CNR2 | Cannabinoid receptor 2; immune modulation | Inflammation, immune response |
| IGF1R | Insulin-like growth factor 1 receptor tyrosine kinase | Growth, cancer |
| PDGFRA | Platelet-derived growth factor receptor alpha | Cancer, development |
| FGFR1 | Fibroblast growth factor receptor 1 | Development, cancer |
| VEGFR2 | Vascular endothelial growth factor receptor 2 | Angiogenesis, cancer |
| MET | Hepatocyte growth factor receptor | Cancer, metastasis |
| ALK | Anaplastic lymphoma kinase | Cancer, neuroblastoma |
| ERBB2 | HER2 receptor tyrosine kinase | Breast cancer, targeted therapy |
| JAK2 | Janus kinase 2; associates with cytokine receptors | Myeloproliferative disorders |
| SRC | Non-receptor tyrosine kinase; downstream of receptors | Cancer, signaling |
| ZAP70 | Tyrosine kinase involved in T cell receptor signaling | Immunodeficiency, autoimmunity |
How Is transmembrane receptor protein kinase activity Regulated?
Transmembrane receptor protein kinase activity is tightly regulated at multiple levels. Ligand availability and affinity control receptor activation, as seen with the insulin receptor. Receptor dimerization or oligomerization is a common regulatory mechanism, promoting autophosphorylation and enhanced catalytic activity. Phosphatases reverse phosphorylation events, providing a counterbalance. In bacteria, sensor kinases like AgrC are regulated by autoinducing peptides and membrane topology. Additionally, downstream kinases such as Src and ZAP70 are temporally regulated following receptor engagement, ensuring signal fidelity.
transmembrane receptor protein kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| INSR | Diabetes, insulin resistance | Knockout mouse, point mutation knock-in |
| EGFR | Non-small cell lung cancer, glioblastoma | Xenograft, CRISPR knockout |
| AGR C | Staphylococcal virulence | Bacterial knockout, overexpression |
| CHEA | Bacterial chemotaxis | Bacterial knockout, point mutation |
| CNR1 | Neuropathic pain, obesity | Knockout mouse, overexpression |
Cancer
Dysregulated transmembrane receptor protein kinase activity drives oncogenesis. Mutations or overexpression of receptor tyrosine kinases such as EGFR, ERBB2, and MET lead to constitutive activation of proliferative signaling pathways. The insulin receptor and IGF1R are also implicated in cancer metabolism and growth. Targeting these kinases with small molecule inhibitors has revolutionized cancer therapy.
Metabolic Disorders
The insulin receptor kinase is critical for glucose homeostasis; impaired activity contributes to insulin resistance and type 2 diabetes. Mutations in INSR cause severe insulin resistance syndromes. Understanding the kinase mechanism informs therapeutic strategies for metabolic diseases.
Bacterial Infections
Bacterial sensor kinases like AgrC regulate virulence factor expression in Staphylococcus aureus. Chemotaxis receptors and their associated kinases are essential for bacterial adaptation and pathogenesis. Inhibiting these kinases is a potential antibacterial strategy.
Neurological and Immune Disorders
Cannabinoid receptors modulate kinase signaling in the nervous system and immune cells, influencing pain, inflammation, and neuroprotection. T cell receptor signaling, which involves tyrosine kinases, is central to autoimmunity and immunodeficiency.
From transmembrane receptor protein kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of INSR kinase activity cause insulin resistance? | INSR knockout cell line or mouse |
| How do point mutations in EGFR affect kinase activity? | CRISPR point mutation knock-in |
| Can AgrC inhibition reduce S. aureus virulence? | AgrC knockout in S. aureus |
| What is the role of CheA autophosphorylation in chemotaxis? | CheA point mutant in E. coli |
| Does overexpression of CNR1 alter kinase signaling? | CNR1 overexpression in neuronal cells |
| How does T cell receptor engagement regulate kinase activity? | ZAP70 knockout Jurkat cells |
How to Study the transmembrane receptor protein kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro kinase assay | Phosphorylation of substrate | Enzyme kinetics, inhibitor screening |
| Phosphoproteomics | Global phosphorylation changes | Substrate identification |
| CRISPR knockout | Loss of gene function | Phenotypic analysis |
| CRISPR knock-in | Precise mutation introduction | Structure-function studies |
| FRET biosensor | Real-time kinase activity | Live-cell signaling dynamics |
| Western blot | Phospho-protein levels | Pathway validation |
| Immunoprecipitation | Protein interactions | Complex assembly |
| RNA-seq | Transcriptional changes | Downstream gene expression |
Kinase Activity Assays
In vitro kinase assays using recombinant receptors and substrate proteins measure phosphotransfer activity by detecting incorporated radioactivity or phospho-specific antibodies. These assays are foundational for characterizing GO:0019199 and testing inhibitors.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics identifies substrate proteins and phosphorylation sites downstream of receptor kinases, providing a global view of signaling networks. This method is valuable for discovering novel substrates and biomarkers.
Genetic Knockout and Knock-in Models
CRISPR-Cas9 knockout and knock-in models allow precise dissection of receptor kinase function in cells and organisms. Point mutations can be introduced to study specific catalytic residues or autophosphorylation sites.
Live-cell Imaging
Fluorescence resonance energy transfer (FRET) biosensors and fluorescently tagged receptors enable real-time visualization of receptor activation and localization. These techniques reveal spatiotemporal dynamics of transmembrane signaling.
How CRISPR Can Be Used to Study GO:0019199 transmembrane receptor protein kinase activity
Knockout
CRISPR knockout of receptor kinase genes such as INSR or EGFR abolishes their activity, enabling studies of loss-of-function phenotypes in cancer, metabolism, and development. Knockout cell lines are valuable for drug sensitivity testing and pathway analysis.
Point Mutation
Point mutations introduced by CRISPR base editing or homology-directed repair can mimic disease-associated mutations or inactivate catalytic residues, allowing precise structure-function analysis of kinase domains. For example, mutating the ATP-binding lysine in EGFR clarifies its role in oncogenic signaling.
Knock-in
Knock-in of tagged or reporter versions of receptor kinases (e.g., GFP-INSR) facilitates live-cell imaging and proteomic studies. Knock-in of patient-derived mutations creates isogenic models for drug testing.
Overexpression
Overexpression of wild-type or mutant receptor kinases via CRISPR activation or lentiviral delivery amplifies signaling, useful for studying gain-of-function effects and identifying downstream targets. Overexpression models are particularly relevant for oncogene addiction studies.
How EDITGENE Supports transmembrane receptor protein kinase activity Research
Researchers studying transmembrane receptor protein kinase activity-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease phenotype. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of receptor kinases and their substrates.
Contact EDITGENE today to design your custom CRISPR model for transmembrane receptor protein kinase activity research.
Frequently Asked Questions About transmembrane receptor protein kinase activity
What is transmembrane receptor protein kinase activity?
It is a molecular function (GO:0019199) where a transmembrane receptor binds a signal and transmits it across the membrane by catalyzing protein phosphorylation using ATP.
What genes are involved in transmembrane receptor protein kinase activity?
Key genes include INSR, EGFR, AGR C, CHEA, and CNR1, among others.
How does transmembrane receptor protein kinase activity work?
A signal binds the receptor, inducing conformational changes that activate the cytoplasmic kinase domain, which then phosphorylates substrate proteins.
What diseases are associated with transmembrane receptor protein kinase activity?
Cancer, diabetes, bacterial infections, and neurological disorders are linked to dysregulation of this activity.
What is the GO ID for transmembrane receptor protein kinase activity?
The GO ID is GO:0019199.
What is the catalytic reaction of transmembrane receptor protein kinase?
The reaction is protein + ATP = phosphoprotein + ADP.
How is transmembrane receptor protein kinase activity regulated?
It is regulated by ligand binding, receptor dimerization, autophosphorylation, and phosphatases.
What research methods are used to study transmembrane receptor protein kinase activity?
Common methods include in vitro kinase assays, phosphoproteomics, CRISPR knockout/knock-in, and live-cell imaging.
Can CRISPR be used to study transmembrane receptor protein kinase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for dissecting receptor kinase function.
What are examples of transmembrane receptor protein kinases?
Examples include the insulin receptor, EGFR, AgrC, and bacterial chemotaxis receptors.
Conclusion
Transmembrane receptor protein kinase activity (GO:0019199) is a cornerstone of cellular signal transduction, enabling communication across membranes through phosphorylation. Its roles in health and disease make it a critical research focus, with CRISPR technologies offering unprecedented precision for functional studies. EDITGENE supports this research with tailored gene editing and screening services.
References
- 1. Liang X et al.. 2018. Receptor-Like Cytoplasmic Kinases: Central Players in Plant Receptor Kinase-Mediated Signaling.. Annu Rev Plant Biol 69:267-299 PMID: 29719165
- 2. Gammeltoft S et al.. 1986. Protein kinase activity of the insulin receptor.. Biochem J 235(1):1-11 PMID: 3017297
- 3. Howlett AC. 2005. Cannabinoid receptor signaling.. Handb Exp Pharmacol PMID: 16596771
- 4. Feige JJ et al.. 1987. Membrane receptors with protein-tyrosine kinase activity.. Biochimie 69(4):379-85 PMID: 2820517
- 5. Burkhardt AL et al.. 1994. Temporal regulation of non-transmembrane protein tyrosine kinase enzyme activity following T cell antigen receptor engagement.. J Biol Chem 269(38):23642-7 PMID: 7522230
- 6. Lina G et al.. 1998. Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus.. Mol Microbiol 28(3):655-62 PMID: 9632266
- 7. Castagna M. 1983. Transmembrane signalling systems.. Biomed Pharmacother 37(8):380-6 PMID: 6320921
- 8. Liu Y et al.. 1997. Receptor-mediated protein kinase activation and the mechanism of transmembrane signaling in bacterial chemotaxis.. EMBO J 16(24):7231-40 PMID: 9405352
